CytRx Corporation Navigation
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Careers
  • Oncology
    • Aldoxorubicin
    • LADR™ Technology
  • Pipeline
  • Investors
    • Overview
    • Stock Information
    • Investor FAQs
    • Fundamentals
    • Analyst Coverage
    • Annual Reports
    • SEC Filings
    • Corporate Governance
    • Presentations
    • Email Alerts
    • Information Request
    • Online Investor Kit
  • News & Events
    • Press Releases
    • Events Calendar
  • Contact
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Careers
  • Oncology
    • Aldoxorubicin
    • LADR™ Technology
  • Pipeline
  • Investors
    • Overview
    • Stock Information
    • Investor FAQs
    • Fundamentals
    • Analyst Coverage
    • Annual Reports
    • SEC Filings
    • Corporate Governance
    • Presentations
    • Email Alerts
    • Information Request
    • Online Investor Kit
  • News & Events
    • Press Releases
    • Events Calendar
  • Contact

SEC Filings

Investor Relations SEC Filings

Need Information?

310-826-5648 info@cytrx.com

Investor Relations

  • Investor Relations
  • Stock Information
  • Investor FAQs
  • Fundamentals
  • Analyst Coverage
  • Annual Reports
  • SEC Filings
  • Corporate Governance
  • Presentations
  • Email Alerts
  • Information Request
  • Online Investor Kit
  • About
  • Oncology
  • Pipeline
  • Investors
  • News & Events
  • Contact

© 2018 CytRx Corporation